Sunwin Stevia International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022
January 11, 2023 at 04:03 pm EST
Share
Sunwin Stevia International, Inc. reported earnings results for the second quarter and six months ended October 31, 2022. For the second quarter, the company reported sales was USD 7.4 million compared to USD 10.11 million a year ago. Net loss was USD 0.217906 million compared to USD 1.17 million a year ago.
For the six months, sales was USD 15.11 million compared to USD 16.38 million a year ago. Net loss was USD 0.339303 million compared to USD 1.63 million a year ago.
Sunwin Stevia International, Inc. sells stevioside, a natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. The Company operates through two segments related to its product lines: Stevioside, which produces and sells a range of purified steviol glycosides with rebaudioside A and stevioside as the principal components; a natural, low calorie sweetener, and OnlySweet, a stevioside-based table top sweetener, and Chinese medicines, which manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by both humans and animals. The Company engages in new product development both through its internal research facilities, industry consultants and specialists to provide research and development for the planting of stevia plants, for the development of biological methods to improve lower-grade stevia product to higher-grade stevia, and for the application of biological method to change the taste of stevia.
SUNWIN STEVIA INTERNATIONAL, INC. 
